Correction to: Preventive migraine treatment in mitochondrial diseases: a case report of erenumab efficacy and literature review

被引：0
|
作者：
Guido Primiano
Eleonora Rollo
Marina Romozzi
Paolo Calabresi
Serenella Servidei
Catello Vollono
机构：
[1] Fondazione Policlinico Universitario Agostino Gemelli IRCCS,Dipartimento Universitario Di Neuroscienze
[2] Università Cattolica del Sacro Cuore,undefined
来源：
Neurological Sciences | 2023年 / 44卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：789 / 789
相关论文
共 50 条
  • [41] Problems with botulinum toxin treatment in mitochondrial cytopathy: case report and review of the literature
    Gioltzoglou, T
    Cordivari, C
    Lee, PJ
    Hanna, MG
    Lees, AJ
    JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2005, 76 (11): : 1594 - 1596
  • [42] Efficacy of Erenumab for the Treatment of Patients with Chronic Migraine in Presence of Medication Overuse
    Tepper, S. J.
    Diener, H.
    Ashina, M.
    Brandes, J. L.
    Friedman, D., I
    Reuter, U.
    Cheng, S.
    Leonardi, D. K.
    Lenz, R. A.
    Mikol, D. D.
    HEADACHE, 2017, 57 : 197 - 197
  • [43] Long-term efficacy of erenumab in patients with episodic migraine who have failed prior preventive migraine therapies
    Reuter, U.
    Schwedt, T.
    Kudrow, D.
    Paemeleire, K.
    Zhang, F.
    Klatt, J.
    Picard, H.
    Chou, D.
    Mikol, D. D.
    EUROPEAN JOURNAL OF NEUROLOGY, 2019, 26 : 637 - 637
  • [44] A systematic review, meta-analysis and meta-regression evaluating the adverse reactions to erenumab in the preventive treatment of migraine
    Pellesi, Lanfranco
    De Icco, Roberto
    Alawie, Hassan Youssef
    Andersen, Morten
    Liang, David
    Amirguliyev, Sarkhan
    Al-Karagholi, Mohammad Al-Mahdi
    Amin, Faisal Mohammad
    Sessa, Maurizio
    EXPERT OPINION ON DRUG SAFETY, 2021, 20 (04) : 467 - 474
  • [45] Comparison study between erenumab, fremanezumab, and galcanezumab in the preventive treatment of high frequency episodic migraine and chronic migraine
    Simone Quintana
    Marco Russo
    Gian Camillo Manzoni
    Paola Torelli
    Neurological Sciences, 2022, 43 : 5757 - 5758
  • [46] Comparison study between erenumab, fremanezumab, and galcanezumab in the preventive treatment of high frequency episodic migraine and chronic migraine
    Quintana, Simone
    Russo, Marco
    Manzoni, Gian Camillo
    Torelli, Paola
    NEUROLOGICAL SCIENCES, 2022, 43 (09) : 5757 - 5758
  • [47] ACUTE CONFUSIONAL MIGRAINE - CASE-REPORT AND REVIEW OF LITERATURE
    HAAN, J
    FERRARI, MD
    BROUWER, OF
    CLINICAL NEUROLOGY AND NEUROSURGERY, 1988, 90 (03) : 275 - 278
  • [48] Acute confusional migraine in CADASIL: A case report and literature review
    Enrico, Ferrante
    Michele, Trimboli
    Cristina, Erminio
    Iolanda, Martino
    Pietro, Tiraboschi
    CLINICAL NEUROLOGY AND NEUROSURGERY, 2022, 216
  • [49] Migraine With Exclusive Olfactory Aura: Case Report and Literature Review
    Tiriticco, Marco
    Vanotti, Alessandra
    Mantica, Davide
    Coppola, Alfonso
    HEADACHE, 2020, 60 (10): : 2544 - 2547
  • [50] Safety and efficacy of erenumab in migraine patients over 65: A retrospective chart review
    Pavalaghanthan, H.
    HEADACHE, 2022, 62 (07): : 928 - 929
12345